Abstract
This chapter presents information on the clinical uses of diagnostic radiopharmaceuticals in nuclear medicine. The presentation is based on individual organs and common diseases. For each organ, a brief description of anatomy, different radiopharmaceuticals, and techniques employed for imaging is included. For tumors and tissue-specific diseases, the pathophysiology of the disease, radiopharmaceuticals, and imaging techniques used for their detection are given. PET/CT and SPECT/CT are commonly used for imaging and their pros and cons discussed. The mechanism of radiotracer uptake in the organ and tissues is elucidated. Wherever appropriate, relevant data are presented in tables. Appropriate illustrations of images depicting normal and/or disease states in humans are provided in support of the contents in the text. Pertinent questions and references related to the chapter are added at the end.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
